Crystalline Management’s SBC Medical Group SBC Stock Holding History

Crystalline Management’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-291,000	Closed	-$3.12M	–	106
2023 Q4	$3.12M	Hold	291,000	–	–	3.96%	6
2023 Q3	$3.11M	Hold	291,000	–	–	2.23%	12
2023 Q2	$2.99M	Buy	291,000 +211,000	+264%	+$2.18M	2.12%	13
2023 Q1	$824K	Buy	+80,000	New	+$827K	0.6%	44

Other funds holding SBC

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TCM

Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

Crystalline Management's SBC Position: Q1 2024 in Review

Crystalline Management sold out of SBC Medical Group (SBC) in Q1 2024, closing a stake of 291,000 shares — an estimated $3.12M sold.

Crystalline Management first reported a position in SBC in Q1 2023 and held it in 4 quarters. The position peaked at $3.12M in Q4 2023. 5 funds tracked by Wall St. Rank hold SBC as of Q1 2024.

Crystalline Management reported no remaining SBC Medical Group position as of Q1 2024 after selling out during the quarter.
Crystalline Management sold 291,000 SBC Medical Group shares in Q1 2024, an estimated $3.12M.
Crystalline Management first reported a position in SBC Medical Group in Q1 2023 and held it in 4 quarters.
Crystalline Management's SBC Medical Group position peaked at $3.12M in Q4 2023.
5 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2024.

Based on Crystalline Management's 13F filing for Q1 2024, filed 10 May 2024.